Karpa Health's LegitScript Deal Bundles Compliance Into Platform Launch
Karpa now offers built-in Healthcare Merchant Certification prep, shortening the compliance gating period that typically delays telehealth go-live by weeks or months.
Certification Workflow Is the New Product Feature
Karpa Health announced September 9 that businesses launching on its telehealth platform will receive accelerated access to LegitScript Healthcare Merchant Certification, with application preparation and dedicated support embedded into the onboarding process. For enterprise buyers, that matters because merchant certification and payment processor approval are often the longest poles in telehealth launch timelines — sometimes taking 8 to 12 weeks — and blocking revenue until resolved. Karpa is now competing on compliance readiness, not just video routing or UI.
The partnership signals a shift in how telehealth platforms differentiate. Buyers no longer evaluate platforms solely on visit volume or clinician network size. Instead, procurement teams are asking which vendor can get them live fastest while meeting state licensure, payment processor standards, and federal advertising rules. Karpa's move suggests other platforms will need to match or exceed this level of pre-built compliance infrastructure to remain competitive in enterprise RFPs.
Workflow Integration Overtakes Video as the Competitive Axis
Teladoc Health's 2026 Telehealth Benchmark Survey, published in late July with Becker's Healthcare, explicitly frames competition around workflow integration rather than standalone video encounters. The report positions interoperability with EHR, scheduling, triage, and care navigation systems as the primary buying criterion, raising the bar for platforms that offer basic synchronous visits without deep enterprise workflow fit.
That creates a clear dividing line. Vendors like Amwell, Doximity, Included Health, and regional virtual-care infrastructure providers now compete on how cleanly they embed into existing operations, not just how many visits they can route. For buyers, this means platform evaluations should include integration testing with existing EHR and scheduling systems before contract signature. Vendors that require custom development or manual data handoffs are losing ground to those with pre-built adapters and documented API performance.
The shift also changes the risk profile. Platforms that cannot integrate cleanly create downstream costs in IT labor, duplicate data entry, and care-coordination errors. Buyers should request reference implementations from customers running similar EHR and scheduling stacks, not just case studies showing visit volume.
Late-Stage Capital Increases Competitive Pressure
Forus, an AI-driven healthcare workflow platform, raised $150 million in a round announced September 8, valuing the company at $3 billion and bringing total funding to more than $300 million. While Forus is broader than a pure telehealth play, the round size and valuation matter because well-capitalized competitors can subsidize product development, undercut pricing, and expand sales coverage faster than bootstrapped or mature vendors.
For buyers, that creates urgency around contract terms. Late-stage funding rounds often precede aggressive market-share campaigns, which can include temporarily lowered pricing, expanded service-level agreements, or bundled add-ons designed to lock in customers before competitors respond. Buyers evaluating telehealth platforms should lock in pricing, SLAs, and exit terms now, before well-funded entrants force incumbents to match on features or price.
The Forus round also signals that investors still back AI-healthcare platforms at scale, which means product expansion and competitive pressure will continue. Buyers should assume the vendor landscape will consolidate or fragment over the next 18 months, making contract portability and data-extraction terms critical in any new agreement.
What to Watch
Compliance-first buying is accelerating. Expect more telehealth vendors to bundle certification workflows, merchant approval assistance, or state licensure tracking into core platform offerings. Buyers should ask vendors for documented time-to-certification benchmarks and reference customers who launched in the same state regulatory environment.
Workflow integration is now table stakes. Platforms that require manual data handoffs or custom API development will struggle in enterprise evaluations. Buyers should prioritize vendors with pre-built EHR adapters, documented integration timelines, and performance SLAs for data sync and scheduling accuracy.
Late-stage funding rounds will continue reshaping vendor dynamics. Buyers should monitor capitalization events among telehealth and adjacent healthcare workflow vendors, as funding often precedes pricing changes, product bundling, or sales expansion. Lock in contract terms before well-funded competitors force market repricing.
Technology decisions, clearly explained.
Weekly analysis of the tools, platforms, and strategies that matter to B2B technology buyers. No fluff, no vendor spin.
